| | 63610-09-3 Basic information More.. |
| Product Name: | Lodoxamidetromethamine | | Synonyms: | Lodoxamidetromethamine;LodoxaMide troMethaMineon;AlMide;LodoxaMide troMetaMol;LodoxaMide troMethaMine salt;U-42585-E;Lodoxamide tromethamine (U 42585 E);2-Amino-2-(hydroxymethyl)propane-1,3-diol hemi(2,2'-((2-chloro-5-cyano-1,3-phenylene)bis(azanediyl))bis(2-oxoacetate)) | | CAS: | 63610-09-3 | | MF: | C15H17ClN4O9 | | MW: | 432.77 | | EINECS: | | | Mol File: | 63610-09-3.mol |  |
Use
Lodoxamidetromethamine, N, N -(2-chloro-5-cyano-m-phenylene)dioxamicacid (Alomide), is a white crystalline, water-solublepowder. The only significant structural similarity betweenlodoxamide and cromolyn and nedocromil is the presence oftwo acidic groups. Lodoxamide is indicated in the treatmentof the ocular disorders including vernal keratoconjunctivitis,vernal conjunctivitis, and vernal keratitis. Lodoxamide isavailable as a 0.1% solution, with each milliliter containing1.78 mg of lodoxamide tromethamine equivalent to 1 mg oflodoxamide. The solution contains the preservative benzalkoniumchloride (0.007%) as well as mannitol, hydroxypropylmethylcellulose, sodium citrate, citric acid, edetatedisodium, tyloxapol, hydrochloric acid and/or sodium hydroxide(to adjust pH), and purified water.The dose for adults and children older than 2 years of ageis 1 to 2 drops in each affected eye 4 times daily for up to 3months. The most frequently reported ocular adverse experienceswere transient burning, stinging, or discomfort oninstillation.
- Lodoxamide tromethamine
-
- US $39.00-86.00 / mg
- 2024-11-19
- CAS:63610-09-3
- Min. Order:
- Purity: 99.58%
- Supply Ability: 10g
- Lodoxamidetromethamine
-
- US $15.00-10.00 / KG
- 2021-07-02
- CAS:63610-09-3
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Lodoxamidetromethamine
-
- US $1.00 / Kg/Drum
- 2019-10-30
- CAS:63610-09-3
- Min. Order: 25Kg/Drum
- Purity: 99.00%
- Supply Ability: 1ton
|
|
63610-09-3
Recommend Suppliers |
|